# Dual Pathways, One Framework: Theoretical Insights into the Benzimidazole × Benzodiazepine Crossroads from o‑Phenylenediamine and 2‑Cyanoacrylate Derivatives

## TL;DR

This paper uses theoretical calculations to explain how two different chemical pathways form benzimidazole and benzodiazepine compounds from the same starting materials.

## Contribution

The study provides a theoretical framework to understand the competing reaction pathways leading to benzimidazole and benzodiazepine derivatives.

## Key findings

- Both reaction pathways are exothermic.
- Formation of methyl 2-cyano-2-(1,3-dihydro-2H-benzo[d]imidazole-2-ylidene)acetate is more thermodynamically favorable.
- Theoretical insights help bridge synthetic applications and mechanistic understanding.

## Abstract

Ketene dithioacetals
represent a significant class of molecules
with a pivotal role in organic synthesis, particularly as versatile
building blocks for the development of novel pharmaceutical compounds.
We employed density functional theory (DFT) calculations in both ethanol
and the gas phase to elucidate the specific mechanism of the reaction
between methyl 2-cyano-3,3-bis­(methylthio)­acrylate and o-phenylenediamine. This approach provides a theoretical basis for
understanding the system’s behavior and reactivity at the molecular
scale. Our study evaluates the competition between two reported products:
4-methylsulfanyl-2-oxo-2,5-dihydro-1H-benzo­[b]­[1,4]­diazepine-3-carbonitrile and methyl 2-cyano-2-(1,3-dihydro-2H-benzo­[d]­imidazole-2-ylidene)­acetate.
The present findings reveal that both reactions are exothermic, with
the formation of methyl 2-cyano-2-(1,3-dihydro-2H-benzo­[d]­imidazole-2-ylidene)­acetate being more
thermodynamically favorable. This combination of experimental evidence
and computational analysis bridges the gap between synthetic applications
and mechanistic understanding, enhancing the design and optimization
of organic reactions.